Author: Olofsson Sara
Publisher: Adis International
ISSN: 1173-8804
Source: BioDrugs, Vol.25, Iss.5, 2011-10, pp. : 299-306
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Phosphodiesterase Type 4 Inhibitors: Potential in the Treatment of Multiple Sclerosis?
By Dinter H.
BioDrugs, Vol. 13, Iss. 2, 2000-02 ,pp. :
Treatment of Multiple Sclerosis with the Interferon- s: Comparative Risks and Benefits
By Herndon R.M.
BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. :